| Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke A Brashear, MF Gordon, E Elovic, VD Kassicieh, C Marciniak, M Do, ... New England Journal of Medicine 347 (6), 395-400, 2002 | 800 | 2002 |
| Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. HC Hendrie, BO Osuntokun, KS Hall, AO Ogunniyi, SL Hui, FW Unverzagt, ... The American journal of psychiatry 152 (10), 1485-1492, 1995 | 615 | 1995 |
| Mutations in the Na+/K+-ATPase α3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism P de Carvalho Aguiar, KJ Sweadner, JT Penniston, J Zaremba, L Liu, ... Neuron 43 (2), 169-175, 2004 | 578 | 2004 |
| Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review)[RETIRED] Report of the Therapeutics and Technology Assessment Subcommittee … DM Simpson, A Blitzer, A Brashear, C Comella, R Dubinsky, M Hallett, ... Neurology 70 (19), 1699-1706, 2008 | 534 | 2008 |
| Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–responsive cervical dystonia A Brashear, MF Lew, DD Dykstra, CL Comella, SA Factor, RL Rodnitzky, ... Neurology 53 (7), 1439-1439, 1999 | 402 | 1999 |
| Inter-and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticity A Brashear, R Zafonte, M Corcoran, N Galvez-Jimenez, JM Gracies, ... Archives of physical medicine and rehabilitation 83 (10), 1349-1354, 2002 | 327 | 2002 |
| The phenotypic spectrum of rapid-onset dystonia–parkinsonism (RDP) and mutations in the ATP1A3 gene A Brashear, WB Dobyns, P de Carvalho Aguiar, M Borg, CJM Frijns, ... Brain 130 (3), 828-835, 2007 | 286 | 2007 |
| Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke MK Childers, A Brashear, P Jozefczyk, M Reding, D Alexander, D Good, ... Archives of physical medicine and rehabilitation 85 (7), 1063-1069, 2004 | 278 | 2004 |
| Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial JM Gracies, A Brashear, R Jech, P McAllister, M Banach, P Valkovic, ... The Lancet Neurology 14 (10), 992-1001, 2015 | 243 | 2015 |
| Distinct neurological disorders with ATP1A3 mutations EL Heinzen, A Arzimanoglou, A Brashear, SJ Clapcote, F Gurrieri, ... The Lancet Neurology 13 (5), 503-514, 2014 | 236 | 2014 |
| Rapid‐onset dystonia‐parkinsonism WB Dobyns, LJ Ozelius, PL Kramer, A Brashear, MR Farlow, TR Perry, ... Neurology 43 (12), 2596-2596, 1993 | 214 | 1993 |
| Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial LA Koman, A Brashear, S Rosenfeld, H Chambers, B Russman, M Rang, ... Pediatrics 108 (5), 1062-1071, 2001 | 212 | 2001 |
| Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia D Truong, M Brodsky, M Lew, A Brashear, J Jankovic, E Molho, O Orlova, ... Parkinsonism & related disorders 16 (5), 316-323, 2010 | 187 | 2010 |
| Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans HC Hendrie, KS Hall, S Hui, FW Unverzagt, CE Yu, DK Lahiri, A Sahota, ... Annals of Neurology: Official Journal of the American Neurological …, 1995 | 184 | 1995 |
| Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study DM Simpson, JM Gracies, SA Yablon, R Barbano, A Brashear, ... Journal of Neurology, Neurosurgery & Psychiatry 80 (4), 380-385, 2009 | 181 | 2009 |
| Cross‐national interrater agreement on the clinical diagnostic criteria for dementia M Baldereschi, MP Amato, P Nencini, G Pracucci, A Lippi, L Amaducci, ... Neurology 44 (2), 239-239, 1994 | 159 | 1994 |
| Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients EP Elovic, A Brashear, D Kaelin, J Liu, SR Millis, R Barron, C Turkel Archives of physical medicine and rehabilitation 89 (5), 799-806, 2008 | 138 | 2008 |
| Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke MF Gordon, A Brashear, E Elovic, D Kassicieh, C Marciniak, J Liu, ... Neurology 63 (10), 1971-1973, 2004 | 133 | 2004 |
| Relationship between disability and health-related quality of life and caregiver burden in patients with upper limb poststroke spasticity QV Doan, A Brashear, PJ Gillard, SF Varon, AM Vandenburgh, CC Turkel, ... PM&R 4 (1), 4-10, 2012 | 132 | 2012 |
| Novel mutations in ATP1A3 associated with catastrophic early life epilepsy, episodic prolonged apnea, and postnatal microcephaly AR Paciorkowski, SS McDaniel, LA Jansen, H Tully, E Tuttle, ... Epilepsia 56 (3), 422-430, 2015 | 120 | 2015 |
Laurie OzeliusAssociate Professor Massachusetts General HospitalVerified email at mgh.harvard.edu
